<p>Cross-validation of this model adjusted p value to less than 0.0134 with following characteristics: AUC: 0.750 (CI: 0.581–0.877), Optimal sensitivity: 59.38 (CI: 40.6–76.3); Optimal specificity: 80.00 (CI: 28.4–99.5); Cut-off: OR = 6.29.</p
AIM:To evaluate the diagnostic accuracy and clinical utility of the fibrosis index based on the four...
Background: Staging hepatic fibrosis by liver biopsy guides prognosis and treatment of hepatitis C, ...
Background: This study aimed at creating a new predictive model of significant fibrosis in chronic h...
<p>Cross-validation of this model adjusted p value to less than 0.0037 with following characteristic...
Background and Aim: Significant hepatic fibrosis is prognostic of liver morbidity and mortality in n...
We developed a predictive model for significant fibrosis in chronic hepatitis B (CHB) based on routi...
OBJECTIVE: We developed a predictive model for significant fibrosis in chronic hepatitis B (CHB) bas...
Aim: To assess the accuracy of a model in diagnosing severe fibrosis/cirrhosis in chronic hepatitis ...
The extent of liver fibrosis predicts long-term outcomes, and hence impacts management and therapy. ...
Background & Aims The extent of liver fibrosis predicts long-term outcomes, and hence impacts manage...
<div><p>Background and Aims</p><p>Noninvasive models have been developed for fibrosis assessment in ...
<p>HOMA, homeostasis model assessment; γ-GT, γ-glutamiltranspherase; PPV, positive predictive value;...
BACKGROUND: Liver biopsy and hepatic venous pressure gradient (HVPG), the gold standard for assessin...
OBJECTIVES AND BACKGROUND To evaluate the performance of 2D share wave elastography from General E...
Liver stiffness measurement (LSM) frequently overestimates the severity of liver fibrosis in nonalco...
AIM:To evaluate the diagnostic accuracy and clinical utility of the fibrosis index based on the four...
Background: Staging hepatic fibrosis by liver biopsy guides prognosis and treatment of hepatitis C, ...
Background: This study aimed at creating a new predictive model of significant fibrosis in chronic h...
<p>Cross-validation of this model adjusted p value to less than 0.0037 with following characteristic...
Background and Aim: Significant hepatic fibrosis is prognostic of liver morbidity and mortality in n...
We developed a predictive model for significant fibrosis in chronic hepatitis B (CHB) based on routi...
OBJECTIVE: We developed a predictive model for significant fibrosis in chronic hepatitis B (CHB) bas...
Aim: To assess the accuracy of a model in diagnosing severe fibrosis/cirrhosis in chronic hepatitis ...
The extent of liver fibrosis predicts long-term outcomes, and hence impacts management and therapy. ...
Background & Aims The extent of liver fibrosis predicts long-term outcomes, and hence impacts manage...
<div><p>Background and Aims</p><p>Noninvasive models have been developed for fibrosis assessment in ...
<p>HOMA, homeostasis model assessment; γ-GT, γ-glutamiltranspherase; PPV, positive predictive value;...
BACKGROUND: Liver biopsy and hepatic venous pressure gradient (HVPG), the gold standard for assessin...
OBJECTIVES AND BACKGROUND To evaluate the performance of 2D share wave elastography from General E...
Liver stiffness measurement (LSM) frequently overestimates the severity of liver fibrosis in nonalco...
AIM:To evaluate the diagnostic accuracy and clinical utility of the fibrosis index based on the four...
Background: Staging hepatic fibrosis by liver biopsy guides prognosis and treatment of hepatitis C, ...
Background: This study aimed at creating a new predictive model of significant fibrosis in chronic h...